Spironolactone oral suspension - CMP Pharma

Drug Profile

Spironolactone oral suspension - CMP Pharma

Alternative Names: CaroSpir

Latest Information Update: 01 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator CMP Pharma
  • Class Antihormones; Antihypertensives; Heart failure therapies; Pregnenes; Vascular disorder therapies
  • Mechanism of Action Aldosterone antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Hyperaldosteronism
  • New Molecular Entity No

Highest Development Phases

  • Marketed Heart failure; Hypertension; Oedema

Most Recent Events

  • 30 Oct 2017 Launched for Heart failure in USA (PO)
  • 30 Oct 2017 Launched for Hypertension (Adjunctive treatment) in USA (PO)
  • 30 Oct 2017 Launched for Oedema in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top